CLABSI (Central Line-Associated Bloodstream Infection)

Central line associated blood stream infections (CLABSI) are among the most frequent health care-associated infections today, with around 250,000 cases per year. CLABSIs cause substantial morbidity and mortality as well as increased costs to the health care system including prolonged hospital stays. A recent CDC report estimated the cost of each CLABSI event at $16,550. While CLABSIs are serious infections, they are often preventable when evidence-based guidelines are followed. The EvidenceCare CLABSI Prevention Protocol incorporates recommendations from the Infection Disease Society of America (IDSA), The Society for Healthcare Epidemiology of America (SHEA), and the Centers for Disease Control (CDC). These recommendations provide guidelines for the insertion of venous catheters, criteria for maintaining the catheter, and implementation of prompt discontinuation strategies.

Stephen Y. Liang, MD
Read More

You May Also Like These Protocols

Pulmonary Embolism (PE)

The diagnostic workup and proper treatment approach to patients with pulmonary embolism can be challenging. The EvidenceCare Pulmonary Embolism pathway…

Learn More

Asthma

The EvidenceCare Asthma pathway allows providers to utilize a structured approach to the management of pediatric and adult patients with…

Learn More

Seizures

The EvidenceCare Seizure pathway provides treatment guidelines for management of seizures in the hospital setting and includes recommendations for new…

Learn More